跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 42,630 条关于
“Novo Holdings REPAIR Impact Fund”
全部
42,630
临床试验
25,982
药物
268
机构
323
资讯
16,057
6个月前
Centauri Therapeutics Secures £6M from AMR Action Fund to Advance Novel Antibiotic CTX-187 Through Phase I Trials
去年
European Commission Approves Novo Holdings' $16.5B Catalent Acquisition
去年
Novo Holdings Makes Landmark Investment in Fungal Biotech Leader Sylvan to Accelerate Sustainable Solutions
去年
Windward Bio Launches with $200 Million to Advance Long-Acting Anti-TSLP Antibody for Asthma and COPD
去年
Novo Holdings Invests in SCHOTT Poonawalla to Strengthen Injectable Drug Packaging Capabilities in India
去年
Novo Holdings and TA Associates Form Strategic Partnership to Accelerate Biocomposites' Growth in Infection Management
3年前
Novo Holdings Leads $200M Series A Investment in Windward Bio for Advanced Respiratory Treatments
去年
Rafael Holdings Completes $25 Million Rights Offering to Fund Trappsol Cyclo Phase 3 Trial for Rare Disease
去年
TISSIUM Receives FDA De Novo Authorization for First Atraumatic Sutureless Peripheral Nerve Repair System
去年
Trial to Evaluate Impact of Simultaneous Perineoplasty on Pelvic Organ Prolapse Repair
第 1 页，共 1606 页
上一页
下一页
